DLD and hepatocellular carcinoma: High expression levels of ATP7A, CDKN2A, DLAT, DLD, DLST, GCSH, GLS, LIPT1, MTF1, PDHA1, and PDHB are the risk factors for HCC patients (Figures 3(a) and 3(b)).